U.S. markets closed

Natural Alternatives International, Inc. (NAII)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
13.09-0.19 (-1.43%)
At close: 1:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close13.28
Bid12.00 x 800
Ask13.16 x 1400
Day's Range13.01 - 13.35
52 Week Range9.11 - 19.93
Avg. Volume31,925
Market Cap83.319M
Beta (5Y Monthly)0.81
PE Ratio (TTM)7.07
EPS (TTM)1.85
Earnings DateFeb 07, 2022 - Feb 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
20% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NAII

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Natural Alternatives Internatio
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.
    Fair Value
    Economic Moat
    8 days agoMorningstar
View more

    Stonegate Capital Partners Updates Coverage On Natural Alternatives International, Inc. (Nasdaq:NAII)

    DALLAS, TX / ACCESSWIRE / November 22, 2021 / Natural Alternatives International, Inc. (Nasdaq:NAII): The full report can be accessed by clicking on the following link: http://stonegateinc.

  • PR Newswire

    Natural Alternatives International, Inc. Announces 2022 Q1 Results

    -Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $3.3 million, or $0.51 per diluted share, on net sales of $38.3 million for the first quarter of fiscal year 2022 compared to net income of $2.3 million, or $0.35 per diluted share, in the first quarter of the prior fiscal year.

  • PR Newswire

    Natural Alternatives International, Inc. To Announce First Quarter 2022 Financial Results

    Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced that it will release its first quarter 2022 financial results on Tuesday, November 9, 2021 after the market close. An updated investor presentation will be available on the investor relations tab of the Company's website after the release.